(MENAFN- GlobeNewsWire - Nasdaq) Integration of Smart Technologies in Delivery Systems to Improve Overall treatment Efficiency Driving Artificial Saliva market GrowthRockville , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global artificial saliva market is estimated at US$ 1.28 billion in 2024 and is predicted to increase at a CAGR of 14.2% from 2024 to 2034, according to Fact, a market research and competitive intelligence provider.
The market is growing at a rapid pace, driven by increasing prevalence of conditions leading to dry mouth, such as Sjögren's syndrome, diabetes, and the side effects of certain medications. Artificial saliva products play a crucial role in providing relief and improving oral health for individuals experiencing xerostomia. These products aim to replicate the natural composition of saliva, offering moisture, lubrication, and pH balance to the oral cavity.
Get Free Sample Copy of This Report:
Consumer preferences are shifting toward artificial saliva products containing natural and bioactive ingredients. This trend is fueled by a desire for solutions that closely mimic the composition of natural saliva, promoting a more holistic approach to oral care. Innovations in artificial saliva formulations include the integration of technology, such as smart delivery systems or IoT-enabled devices. These advancements are predicted to enhance user experience, providing real-time monitoring and effective personalized solutions.
| Report Attribute | Details |
| Value Projection (2034) | US$ 4.82 Billion |
| Growth Rate (2024-2034) | 14.2% CAGR |
| No. of pages | 170 Pages |
| No. of Tables | 84 Tables |
| No. of Figures | 112 Figures |
Key Takeaways from Market Study
The global artificial saliva market is projected to reach US$ 4.82 billion by 2034-end. Sales of artificial saliva products in the United States are foreseen to rise at a CAGR of 14.7% from 2024 to 2034. Growing organic trend in Germany is driving high demand for natural ingredient-based artificial saliva solutions. Sales of artificial saliva products in Japan are forecasted to expand at a CAGR of 10.6% through 2034. Demand for artificial saliva sprays is calculated at a market value of US$ 400.5 million for 2024.
“Rising prevalence of medical conditions such as autoimmune disorders and diabetes are leading to the high incidence of xerostomia, driving demand for effective artificial saliva solutions,” says a Fact analyst.
Key Companies Profiled in This Report
ICPA Health Products Ltd. Lee BioSolutions CCMed Group Midatech Pharma PLC Bausch Health Companies Inc. Parnell Pharmaceuticals, Inc. Forward Science Laboratorios KIN S.A. Valeant Pharmaceuticals International, Inc. Biocosmetics Laboratories S.L. Perrigo Company PLC GlaxoSmithKline Plc Cipla Inc. Mission Pharmacal Company Fresenius Kabi AG
Competitive Analysis
Key market players are following several organic and inorganic strategies to increase their market shares and reach a wider customer base. Leading manufacturers are focusing on developing specialized artificial saliva solutions tailored to specific medical conditions such as Sjögren's syndrome and diabetes. Customization aligns with the diverse needs of patients and contributes to targeted efficacy.
Get Customization on this Report for Specific Research Solutions:
More Valuable Insights on Offer
Fact, in its new offering, presents an unbiased analysis of the global artificial saliva market, presenting historical demand data for 2018 to 2023 and forecast statistics for 2024 to 2034.
The study divulges essential insights into the market based on product (oral sprays, oral solutions, oral liquids, gels, powders), age group (adults, pediatrics), and distribution channel (hospital pharmacies, retail pharmacies, mail-order pharmacies, hypermarkets & supermarkets), across six major regions of the world (North America, Latin America, Europe, East Asia, South Asia & Oceania, and MEA).
Explore More Related Studies Published by Fact Research:
Oral Hygiene Market : The global oral hygiene market is anticipated to evolve at a CAGR of 5% from 2023 to 2033. The market stands at US$ 52 billion in 2023 and is thereby predicted to reach US$ 85 billion by 2033-end.
Oral Solid Dosage Pharmaceutical Market : The global oral solid dosage pharmaceutical market was valued at US$ 524.6 billion in 2021 and is expected to top US$ 1.03 trillion in value by the end of 2032.
Oral Health Ingredient Market : The global oral health ingredient market size is valued at US$ 7 Billion in 2023, and is predicted to reach US$ 10.36 Billion by 2033-end
About Fact :
Fact is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: ...
Follow Us: LinkedIn | Twitter | Blog
MENAFN07122023004107003653ID1107552346
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.